News
09-12-2021, 10:47 PM
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, announced results from their Phase 0/1 clinical trial of ribociclib plus everolimus in patients with high-grade glioma (HGG).
More... (https://www.news-medical.net/news/20210913/Results-from-Phase-01-trial-of-ribociclib-plus-everolimus-in-patients-with-high-grade-glioma-announced.aspx)
More... (https://www.news-medical.net/news/20210913/Results-from-Phase-01-trial-of-ribociclib-plus-everolimus-in-patients-with-high-grade-glioma-announced.aspx)